PROSTAGLANDIN-E2 LEVELS OVER THE COURSE OF GLYCERYL TRINITRATE PROVOKED MIGRAINE ATTACKS 111 5 41. Negishi M, Sugimoto Y, Ichikawa A. Molecular mechanisms of diverse actions of prostanoid receptors. Biochim Biophys Acta. 1995;1259(1):109-119. 42. Kawabata A. Prostaglandin E2 and pain--an update. Biol Pharm Bull. 2011;34(8):11703117. 43. Uda R, Horiguchi S, Ito S, Hyodo M, Hayaishi O. Nociceptive effects induced by intrathecal administration of prostaglandin D2, E2, or F2 alpha to conscious mice. Brain Res. 1990;510(1):26-32. 44. Pradhan SS, Salinas K, Garduno AC, et al. Anti-Inflammatory and Neuroprotective Effects of PGE(2) EP4 Signaling in Models of Parkinson’s Disease. J Neuroimmune Pharmacol. 2017;12(2):292-304. 45. Liang X,Wang Q,Shi J,et al.The prostaglandin E2 EP2 receptor accelerates disease progression and inflammation in a model of amyotrophic lateral sclerosis. Ann Neurol. 2008;64(3):304314. 46. Andreasson K. Emerging roles of PGE2 receptors in models of neurological disease. Prostaglandins Other Lipid Mediat. 2010;91(34):104-112. 47. Tilley SL, Coffman TM, Koller BH. Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J Clin Invest. 2001;108(1):1523. 48. Younis S, Christensen CE, Toft NM, et al. Investigation of distinct molecular pathways in migraine induction using calcitonin generelated peptide and sildenafil. Cephalalgia. 2019;39(14):1776-1788. 49. Montine TJ, Sidell KR, Crews BC, et al. Elevated CSF prostaglandin E2 levels in patients with probable AD. Neurology. 1999;53(7):1495-1498.
RkJQdWJsaXNoZXIy MTk4NDMw